NYSE:PRGOPerrigo Stock Price, Forecast & News

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRGO shares have increased by 25.6% and is now trading at $57.84. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Perrigo.

Perrigo is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Perrigo.

Perrigo Company PLC (NYSE:PRGO) posted its quarterly earnings data on Thursday, April, 30th. The company reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $0.05. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.33 billion. Perrigo had a net margin of 3.77% and a return on equity of 9.72%. The business's revenue for the quarter was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $1.07 earnings per share. View Perrigo's earnings history.

Perrigo declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, May 29th will be paid a dividend of $0.225 per share on Tuesday, June 16th. This represents a $0.90 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date of this dividend is Thursday, May 28th. View Perrigo's dividend history.

8 brokers have issued 12 month price objectives for Perrigo's stock. Their forecasts range from $53.00 to $70.00. On average, they expect Perrigo's share price to reach $58.43 in the next twelve months. This suggests a possible upside of 1.0% from the stock's current price. View analysts' price targets for Perrigo.

News articles about PRGO stock have trended negative this week, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Perrigo earned a news impact score of -2.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Perrigo.

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Netflix (NFLX), Allergan (AGN), Johnson & Johnson (JNJ), Celgene (CELG), Intel (INTC) and QUALCOMM (QCOM).

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Harel Insurance Investments & Financial Services Ltd. (0.50%), Manning & Napier Group LLC (0.29%), State of Alaska Department of Revenue (0.09%), Envestnet Asset Management Inc. (0.01%), Contravisory Investment Management Inc. (0.01%) and Everence Capital Management Inc. (0.01%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma. View institutional ownership trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki, and Todd W Kingma. View insider buying and selling activity for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., State of Alaska Department of Revenue, Everence Capital Management Inc., Contravisory Investment Management Inc., Envestnet Asset Management Inc., and Fruth Investment Management. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Murray S Kessler, Svend Andersen, Theodore R Samuels II, and Todd W Kingma. View insider buying and selling activity for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $57.84.

Perrigo has a market capitalization of $7.88 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe.

The official website for Perrigo is www.perrigo.com.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]